Emyria Limited Files Final Director's Interest Notice for Sir John Tooke Following Board Departure

Aakashdeep

12 November 2026 05:39 PM AEDT

Emyria Limited Files Final Director's Interest Notice for Sir John Tooke Following Board Departure

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Emyria Limited (ASX:EMD) has lodged a final director's interest notice with the ASX for Sir John Tooke, disclosing that he ceased to be a director on 12 November 2026, with the filing confirming nil remaining securities held directly or indirectly.

Key Points

Sir John Tooke ceased to be a director of Emyria Limited on 12 November 2026
The final director's interest notice reports nil securities held as registered holder and nil securities held as non-registered holder
500,000 unlisted options exercisable at $0.45, held by Academic Health Solutions Ltd, lapsed on 13 June 2023
1,000,000 unlisted options exercisable at $0.114, held by Sir John Edward Tooke, lapsed on 13 November 2024

Director Cessation and Filing Details

Emyria Limited filed an Appendix 3Z Final Director's Interest Notice under ASX Listing Rule 3.19A.3 in relation to Sir John Tooke. The notice states that the date of the last previous director's interest notice for Sir John Tooke was 13 November 2020. According to the filing, Sir John Tooke ceased to hold the position of director of Emyria Limited on 12 November 2026. The filing was submitted in accordance with section 205G of the Corporations Act.

Securities Held at Departure

The final director's interest notice discloses that Sir John Tooke held nil securities as a registered holder at the time of his departure from the board. Similarly, Part 2 of the notice, covering securities of which the director is not the registered holder, also records nil securities. The filing notes that any previously held interests have been extinguished, with the nil positions reflecting the lapse of unlisted options that had been associated with Sir John Tooke and a related entity prior to his departure.

Lapsed Options Disclosed in Final Notice

The filing sets out details of two tranches of unlisted options that lapsed prior to the director's cessation date. A total of 500,000 unlisted options exercisable at $0.45 on or before 13 June 2023, held by Academic Health Solutions Ltd, lapsed on 13 June 2023. Additionally, 1,000,000 unlisted options exercisable at $0.114 on or before 13 November 2024, held by Sir John Edward Tooke, lapsed on 13 November 2024. No interests in contracts were disclosed, with Part 3 of the filing recording not applicable.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.